{{Rsnum
|rsid=11158493
|Gene=PPP2R5E
|Chromosome=14
|position=63486804
|Orientation=plus
|GMAF=0.3554
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PPP2R5E
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 70.8 | 25.7 | 3.5
| HCB | 51.8 | 40.1 | 8.0
| JPT | 33.6 | 57.5 | 8.8
| YRI | 2.0 | 25.9 | 72.1
| ASW | 7.0 | 43.9 | 49.1
| CHB | 51.8 | 40.1 | 8.0
| CHD | 47.2 | 39.8 | 13.0
| GIH | 65.3 | 28.7 | 5.9
| LWK | 0.0 | 37.3 | 62.7
| MEX | 84.5 | 15.5 | 0.0
| MKK | 3.8 | 39.7 | 56.4
| TSI | 65.7 | 29.4 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21659360
|Trait=None
|Title=Association between SNP-genotype and chronic lymphocytic leukemia outcome in a randomized chemotherapy trial.
|RiskAllele=
|Pval=9E-7
|OR=2.0000
|ORtxt=[1.56-2.56]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}